DAPAGLIFLOZIN: COST EFFECTIVENESS AS AN ADD-ON THERAPY TO METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES IN ECUADOR
Elgart, J.F ; Prestes, M ; Gonzalez, L ; Solis Sanchez, C ; Acosta, W ; Solorzano, J ; Gagliardino, J.J
Value in health, 2016-05, Vol.19 (3), p.A202-A202 [Revista revisada por pares]Texto completo disponible